PMID: 9438396Jan 23, 1998Paper

Juvenile dermatomyositis and polymyositis: a follow-up study of long-term sequelae

Southern Medical Journal
C H CollisonJ Snyder

Abstract

Juvenile dermatomyositis/polymyositis (DMS/PM) are childhood inflammatory myopathies that normally affect children between 2 and 15 years of age. The disease is manifested as severe proximal muscle weakness and, in JDMS, as a characteristic cutaneous eruption. It is difficult to predict the course of the disease. This study is aimed at objectively assessing the long-term morbidity of dermatomyositis/polymyositis in children. Twelve cases of JDMS/PM identified through chart review were evaluated by physical and dermatologic examination, muscle testing, ultrasonography, and magnetic resonance imaging (MRI). The patient population included 6 male and 6 female patients with a mean age of 18.8 years (standard deviation 12.4). The mean age at onset of JDMS/PM was 5.8 years (SD 2.8), and the mean time from onset of symptoms to beginning of the study was 10.1 years (SD 9.3). The mean duration of corticosteroid therapy was 53.1 months (SD 40.5), with patients reporting an average of 1.7 relapses (SD 1.5). Patients compared their own activity level with that of healthy control subjects, and on a scale of 1 to 5 with 5 being normal, their mean score was 3.9 (SD 0.9). Fifty-eight percent of the patients had at least one residual finding on...Continue Reading

Citations

Mar 24, 2004·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Francis O WalkerJames Caress
Feb 26, 2000·International Journal of Dermatology·J GhateJ L Jorizzo
Oct 22, 2003·Current Opinion in Rheumatology·Michael O Harris-Love
Nov 24, 2005·Current Rheumatology Reports·Adam Huber, Brian M Feldman
Aug 21, 2009·Current Rheumatology Reports·Ronald S Adler, Giovanna Garofalo
Apr 22, 2008·Journal of the American Academy of Dermatology·Luciano J Iorizzo, Joseph L Jorizzo
Jun 23, 2004·Neurologic Clinics·Francis O Walker
Jul 26, 2011·The Journal of Pediatrics·Micah J EimerLauren M Pachman
Apr 20, 2000·São Paulo Medical Journal = Revista Paulista De Medicina·M O HilárioH Lederman
Aug 6, 2005·Arthritis and Rheumatism·Y-L ChungUNKNOWN Juvenile Dermatomyositis Disease Activity Collaborative Study Group
Feb 9, 2000·Rheumatology·I Lundberg, Y Chung
Jan 22, 2019·Expert Review of Neurotherapeutics·Shereen ParamalingamMerrilee Needham
Aug 7, 2017·International Journal of Rheumatic Diseases·Joana Sousa NevesFilipa Teixeira
May 22, 2021·Seminars in Musculoskeletal Radiology·Grzegorz PracońIwona Sudoł-Szopińska
Jul 29, 2000·Seminars in Pediatric Neurology·N F Schor
Nov 19, 2021·Rheumatology·Gulnara MamyrovaLisa G Rider

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.